These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2717658

  • 1. Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders.
    Okuma T, Yamashita I, Takahashi R, Itoh H, Kurihara M, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K.
    Pharmacopsychiatry; 1989 Mar; 22(2):47-53. PubMed ID: 2717658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD, Heaton RK, Paulsen JS, McAdams LA, Heaton SC, Jeste DV.
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Oxcarbazepine in the treatment of affective and schizoaffective disorders].
    Dietrich DE, Kropp S, Emrich HM.
    Fortschr Neurol Psychiatr; 2003 May; 71(5):255-64. PubMed ID: 12740757
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reversible pitch perception deficit caused by carbamazepine.
    Miyaoka T, Seno H, Itoga M, Horiguchi J.
    Clin Neuropharmacol; 2000 May; 23(4):219-21. PubMed ID: 11020128
    [Abstract] [Full Text] [Related]

  • 9. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study.
    Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T.
    Eur Arch Psychiatry Clin Neurosci; 1997 May; 247(1):42-50. PubMed ID: 9088805
    [Abstract] [Full Text] [Related]

  • 10. Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission.
    Bottlender R, Strauss A, Möller HJ.
    Schizophr Res; 2010 Jan; 116(1):9-15. PubMed ID: 19896334
    [Abstract] [Full Text] [Related]

  • 11. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS.
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of schizoaffective disorders.
    Goodnick PJ, Meltzer HY.
    Schizophr Bull; 1984 Aug; 10(1):30-48. PubMed ID: 6142525
    [Abstract] [Full Text] [Related]

  • 15. Symptom dimensions in acutely ill patients with affective, schizoaffective, and schizophrenic disorders.
    Fleck DE, Corey KB, Strakowski SM.
    Schizophr Res; 2001 May 30; 50(1-2):131-2. PubMed ID: 11378321
    [No Abstract] [Full Text] [Related]

  • 16. The longitudinal course of schizoaffective disorders. A prospective follow-up study.
    Grossman LS, Harrow M, Fudala JL, Meltzer HY.
    J Nerv Ment Dis; 1984 Mar 30; 172(3):140-9. PubMed ID: 6699629
    [Abstract] [Full Text] [Related]

  • 17. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
    Kaschka WP, Thürauf N, Mokrusch T, Korth M.
    Pharmacopsychiatry; 1988 Nov 30; 21(6):404-6. PubMed ID: 3244776
    [No Abstract] [Full Text] [Related]

  • 18. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ, Curtis JL, Jann MW.
    Clin Pharm; 1985 Nov 30; 4(4):425-34. PubMed ID: 2864160
    [Abstract] [Full Text] [Related]

  • 19. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
    Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS.
    Pharmacopsychiatry; 1989 Jan 30; 22(1):34-7. PubMed ID: 2652160
    [Abstract] [Full Text] [Related]

  • 20. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.